Scholars@Duke publication: Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation

Publication , Conference

Lopes, RD

2013

Duke Scholars

Author Christopher Bull Granger Medicine, Cardiology

Author Renato Delascio Lopes Medicine, Cardiology

Publication Date

2013

Conference Name

American College of Cardiology Scientific Session

Related Subject Headings

Cardiovascular System & Hematology
3201 Cardiovascular medicine and haematology
1102 Cardiorespiratory Medicine and Haematology

Citation

APA

Chicago

ICMJE

MLA

NLM

Lopes, R. D. (2013). Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation. Presented at the American College of Cardiology Scientific Session.

Lopes, R. D. “Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation,” 2013.

Lopes RD. Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation. In 2013.

Lopes, R. D. Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation. 2013.

Lopes RD. Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation. 2013.

Publication Date

2013

Conference Name

American College of Cardiology Scientific Session

Related Subject Headings

Cardiovascular System & Hematology
3201 Cardiovascular medicine and haematology
1102 Cardiorespiratory Medicine and Haematology